1. Home
  2. ENTX vs DIBS Comparison

ENTX vs DIBS Comparison

Compare ENTX & DIBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$2.91

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Logo 1stdibs.com Inc.

DIBS

1stdibs.com Inc.

HOLD

Current Price

$4.56

Market Cap

149.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTX
DIBS
Founded
2010
2000
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
147.4M
149.9M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
ENTX
DIBS
Price
$2.91
$4.56
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$9.00
$7.00
AVG Volume (30 Days)
351.5K
81.8K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
22.45
EPS
0.22
N/A
Revenue
$42,000.00
$89,620,000.00
Revenue This Year
N/A
$3.12
Revenue Next Year
N/A
$1.72
P/E Ratio
$13.68
N/A
Revenue Growth
N/A
1.54
52 Week Low
$0.91
$2.50
52 Week High
$4.20
$6.62

Technical Indicators

Market Signals
Indicator
ENTX
DIBS
Relative Strength Index (RSI) 50.89 48.46
Support Level $2.73 $4.46
Resistance Level $3.10 $4.91
Average True Range (ATR) 0.23 0.25
MACD -0.06 0.01
Stochastic Oscillator 16.46 47.78

Price Performance

Historical Comparison
ENTX
DIBS

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

About DIBS 1stdibs.com Inc.

1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The company has a single reportable and operating segment that contains one reporting unit, which consists of the company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.

Share on Social Networks: